National · Lead Story
Medicare Is Paying for Hemp CBD Products That the FDA Hasn’t Approved. That’s the Problem.
CMS launched a pilot on April 1 that lets Medicare-connected organizations give patients up to $500 in hemp-derived CBD products. The FDA hasn’t approved any of them. Now there’s a federal lawsuit — and Congress may soon pull the rug out from under the whole program.
Morgan Ellis
·
·
6 min read